0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 158127 results.
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The “Zanubrutinib Industry Forecast” looks at past sales and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2023...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2022...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. According to our Publisher latest study, the global Zanubrutinib...
Catalog:
GIR
February 2023
Price: USD 3,480.00
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Dual Specificity...
Catalog:
9Dimen Research
September 2021
Price: USD 3,200.00
Summary Publisher estimates that the Kinase Inhibitors market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
June 2021
Price: USD 2,000.00
Zanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market is projected to grow from US$...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The “Quizartinib Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2023 and is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Radotinib is a tyrosine kinase inhibitor. The “Radotinib Industry Forecast” looks at past sales and reviews total world Radotinib sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Quizartinib is a small molecule receptor tyrosine kinase inhibitor. The global Quizartinib market is projected to grow from US$ million in 2023 to US...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
